In a report by De Belder and colleagues they have demonstrated a decrease in both eNOS activity and expression [34], while other studies have shown an increase in the eNOS activity and expression in CAD patients which is regarded as a compensatory mechanism against CAD [35, 36]. The gene discussed is NOS3; the disease is coronary artery disorder.